Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer

OBJECTIVE: To determine whether 5-α reductase inhibitor (5-ARI) use delays cancer reclassification in an active surveillance (AS) cohort. PATIENTS AND METHODS: We performed a retrospective study of 587 men enrolled in an AS programme, who had no history of 5-ARI use. Chi-squared and t-tests were use...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BJU Int
Asıl Yazarlar: Ross, Ashley E., Feng, Zhaoyong, Pierorazio, Phillip M., Landis, Patricia, Walsh, Patrick C., Carter, H. Ballentine, Trock, Bruce J., Schaeffer, Edward M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489446/
https://ncbi.nlm.nih.gov/pubmed/22289613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-410X.2011.10875.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller